AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

Boston Scientific BSX is experiencing a temporary cooling-off period after its strong run in 2024, where the stock climbed 54.5%, banking on robust financial performance and product advancements ...

Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...

The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...

The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Discover the top gainers and losers in the S&P 500 Healthcare Index and stay updated on major news like J&J's $55B investment and Pfizer's Haleon stake exit.

The AID system used in the study was Tandem Diabetes Care's t:slim X2 insulin pump with Control-IQ+ technology ... MannKind Corporation, Medtronic MiniMed, Novo Nordisk, and Sequel Med Tech.

Mar. 17, 2025 — A new study may help to explain why there is an over-representation of women experiencing chronic pain compared to men and why pain medication may not be as effective for women ...